Last Updated: May 10, 2026

List of Excipients in API DAPAGLIFLOZIN


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing DAPAGLIFLOZIN

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
AstraZeneca Pharmaceuticals LP FARXIGA dapagliflozin 0310-6205 ANHYDROUS LACTOSE
AstraZeneca Pharmaceuticals LP FARXIGA dapagliflozin 0310-6205 CELLULOSE, MICROCRYSTALLINE
AstraZeneca Pharmaceuticals LP FARXIGA dapagliflozin 0310-6205 CROSPOVIDONE
AstraZeneca Pharmaceuticals LP FARXIGA dapagliflozin 0310-6205 MAGNESIUM STEARATE
AstraZeneca Pharmaceuticals LP FARXIGA dapagliflozin 0310-6205 SILICON DIOXIDE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Start Trial

Excipients in ANDA-approved (generic) drugs containing DAPAGLIFLOZIN

Company Ingredient NDC Excipient
Teva Pharmaceuticals Inc dapagliflozin 0480-3527 ANHYDROUS LACTOSE
Teva Pharmaceuticals Inc dapagliflozin 0480-3527 CELLULOSE, MICROCRYSTALLINE
Teva Pharmaceuticals Inc dapagliflozin 0480-3527 CROSPOVIDONE
Teva Pharmaceuticals Inc dapagliflozin 0480-3527 FERRIC OXIDE YELLOW
Teva Pharmaceuticals Inc dapagliflozin 0480-3527 POLYETHYLENE GLYCOL 3350
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Start Trial

Detailed excipient profiles for DAPAGLIFLOZIN

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM

DAPAGLIFLOZIN drug variants containing CARBOXYMETHYLCELLULOSE SODIUM

Company Ingredient NDC
AstraZeneca Pharmaceuticals LP dapagliflozin and metformin hydrochloride 0310-6270
Macleods Pharmaceuticals Limited dapagliflozin and metformin hydrochloride 33342-406
Aurobindo Pharma Limited dapagliflozin and metformin hydrochloride 59651-154
Sun Pharmaceutical Industries Inc dapagliflozin and metformin hydrochloride 63304-026
Prasco Laboratories dapagliflozin and metformin hydrochloride 66993-362
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: COPOVIDONE

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: CROSPOVIDONE

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FD&C YELLOW NO. 6 ALUMINUM LAKE

Excipient focus: FERRIC OXIDE RED

DAPAGLIFLOZIN drug variants containing FERRIC OXIDE RED

Company Ingredient NDC
Cipla USA Inc dapagliflozin 69097-388
Macleods Pharmaceuticals Limited dapagliflozin and metformin hydrochloride 33342-406
Sun Pharmaceutical Industries Inc dapagliflozin and metformin hydrochloride 63304-026
Lupin Pharmaceuticals Inc dapagliflozin and metformin hydrochloride 70748-101
Novadoz Pharmaceuticals LLC dapagliflozin and metformin hydrochloride 72205-434
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: FERROUS OXIDE

Excipient focus: GLYCERYL MONO- AND DICAPRYLOCAPRATE

Excipient focus: GLYCERYL MONOCAPRYLOCAPRATE

Excipient focus: HYDROCHLORIC ACID

Excipient focus: HYDROXYETHYL CELLULOSE

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2208

DAPAGLIFLOZIN drug variants containing HYPROMELLOSE 2208

Company Ingredient NDC
Sandoz Inc dapagliflozin 0781-5985
AstraZeneca Pharmaceuticals LP dapagliflozin and metformin hydrochloride 0310-6270
Aurobindo Pharma Limited dapagliflozin and metformin hydrochloride 59651-154
Sun Pharmaceutical Industries Inc dapagliflozin and metformin hydrochloride 63304-026
Prasco Laboratories dapagliflozin and metformin hydrochloride 66993-362
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: LACTOSE

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE

Excipient focus: MAGNESIUM ALUMINOMETASILICATE TYPE I-B

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MANNITOL

Excipient focus: MICROCRYSTALLINE CELLULOSE 101

Excipient focus: MICROCRYSTALLINE CELLULOSE 112

Excipient focus: POLOXAMER 407

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 3350

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOL 4000

Excipient focus: POLYETHYLENE GLYCOL 6000

Excipient focus: POLYOXYL 40 HYDROGENATED CASTOR OIL

Excipient focus: POLYSORBATE 80

Excipient focus: POLYVINYL ALCOHOL

Excipient focus: POVIDONE

Excipient focus: POVIDONE K90

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM STEARYL FUMARATE

Excipient focus: STEARIC ACID

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIETHYL CITRATE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links